SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Executive Leadership ▸ Jayashree Aiyar
Jayashree has over 30 years of experience as a molecular pharmacologist and has led drug discovery programs in global organizations in the US like AstraZeneca, Merck, Ambrx and Theravance and Jubilant Biosys in India. Jayashree has more than 30 peer-reviewed publications and book chapters to her credit and two issued patents.
Jayashree joined Syngene in 2016 to lead the Discovery Biology function which has grown significantly under her leadership. In her role as Chief Scientific Officer, Jayashree plays a pivotal role in driving our scientific strategy and innovation in R&D, as well as strengthen academic and industry collaborations, ensuring that Syngene continues to lead with cutting-edge solutions for our clients.
Jayashree holds a Ph.D in Immunology from the All India Institute of Medical Sciences, New Delhi and post-doctoral research at the California Institute of Technology and the University of California at Irvine.
© 2025. Syngene International Limited